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Abstract -------------------------------------------------------------------------------------------------------------------------- 
 
Objectives: To adapt the Components of Primary Care Index (CPCI) to be applicable to oncology outpatients and to assess the 
reliability and validity of the adapted instrument (renamed the Medical Care Questionnaire (MCQ)).  
Methods: The development and validation of the MCQ took place in four phases. Phase 1 reviewed the literature and examined 
existing measures. In Phase 2 the selected instrument (CPCI) was reviewed by a panel of experts using a stepwise consensus 
procedure. In Phase 3 the adapted 21-item MCQ was administered to 200 outpatients attending oncology appointments. The 
instrument was refined to 15-items and in Phase 4 it was completed by 477 oncology outpatients. The psychometric properties of 
the new instrument were assessed using exploratory factor analysis, confirmatory factor analysis, multi-trait scaling analysis and by 
comparing MCQ scores between known groups. 
 
Results: Exploratory factor analysis of the 15-item MCQ suggested 3 subscales with acceptable to good reliability:  ?Communication ? 
ɲ=0.69;  ?ŽŽƌĚŝŶĂƚŝŽŶ ?ɲA? ? ? ? ? ?ĂŶĚ ?Preferences ? ɲ=0.75. Comparing known groups showed that patients who saw fewer doctors 
ĚƵƌŝŶŐƚŚĞŝƌĐůŝŶŝĐǀŝƐŝƚƐƌĞƉŽƌƚĞĚƐƚƌŽŶŐĞƌ ?WƌĞĨĞƌĞŶĐĞƐ ?ƚŽƐĞĞƚŚĞŝƌƵƐƵĂůĚŽĐƚŽƌĂŶĚƌĂƚĞĚ ?ŽŵŵƵŶŝĐĂƚŝŽŶ ?ǁŝƚŚƚŚĞŝƌĚŽĐƚŽƌƐĂƐ
better than patients who saw more doctors during their clinic visits.  
Conclusion: The MCQ demonstrates good psychometric properties in the target population. It is a brief and simple to use 
instrument, which provides a valid perspective on patientƐ ?ĞǆƉĞƌŝĞŶĐĞƐof communicating with doctors and their perceptions of 
the continuity and coordination of their cancer care. 
 
Keywords: cancer, communication, patient-reported outcomes, psychometric properties, questionnaire development. 
-------------------------------------------------------------------------------------------------------------------------------------- 
 
Introduction  
 
/Ŷ ƚŚĞ ůĂƚĞ  ? ? ? ? ?Ɛ ŚŽƐƉŝƚĂů ďĂƐĞĚ ŽŶĐŽůŽŐǇ ƉƌĂĐƚŝĐĞƐ
began to change with the development of new and 
effective systemic cancer treatments. The delivery of 
cancer care became more complex with increasing 
number of patients surviving for longer and increasing 
number of oncologists and nurses being involved in 
the care delivery.  Multi-disciplinary teams (MDTs) 
were formed to ensure involvement of the necessary 
experts in diagnosis, treatment modalities, and patient 
care, so that all patients received consistently high 
quality and timely treatment. Such multidisciplinary 
and team-based structures are common within UK 
hospitals for the delivery of a variety of medical 
interventions. However, the involvement of a large 
number of medical staff for each patient can have a 
negative impact on the continuity of care that patients 
receive if medical staff vary in their ability to elicit 
important symptoms or functional limitations, to 
assess change over time, or to make an objective 
medical record of problems [1-3]. Continuity of care is 
an important issue for modern health service 
provision, yet assessing continuity is not always 
straightforward, in part because it has been a difficult 
subject to define.  
 
Early definitions described good continuity of care 
quantitatively as a succession of visits by a patient to 
the same health care provider [4]. More recent 
definitions have made attempts to evaluate continuity 
of care within the context of a multidisciplinary and 
multi-service health system. As part of a National 
Health Service (NHS) scoping exercise, Freeman et al 
[5] identified three aspects of health care that were 
considered important to continuity of care: seeing the 
same health care provider over time; having continuity 
when care is shared or transferred between health 
care providers; and having continuity of information 
across medical records and providers. Continuity of 
care is expected to have an impact on the quality of 
care that patients receive and may improve patient 
outcomes. For example, higher experienced continuity 
may be associated with lower health care needs in the 
future [6]. However, it can be difficult to elicit reliable 
self-reports of ƉĂƚŝĞŶƚƐ ? perceptions of the care they 
receive. For example in oncology, patients tend to 
report high levels of satisfaction with their care and 
appear reluctant to rate their medical team negatively 
[7]. Therefore, measuring satisfaction with care may 
ŶŽƚ ŽĨĨĞƌ Ă ƚƌƵĞ ƌĞĨůĞĐƚŝŽŶ ŽĨ ƉĂƚŝĞŶƚƐ ? experiences of 
the continuity of their care. 
 
Within the context of changes to patient care and 
management in oncology during the late  ? ? ? ? ?Ɛ ǁĞ
Article Published in Value In Health  
2009, Volume 12 (8) 1180-1186 
 2 
ǁŝƐŚĞĚ ƚŽ ĞǆĂŵŝŶĞ ƉĂƚŝĞŶƚƐ ? ƉĞƌĐĞƉƚŝŽŶƐ ŽĨ ƚŚĞ
continuity of their care. However, at this time there 
were no cancer-specific instruments suitable for 
measuring continuity of care in secondary/tertiary 
health services. As such, we adapted an existing 
instrument that assessed continuity of care in the 
primary health care setting. Over several years we 
have continued to develop this instrument and have 
used it in randomised trials to document patientƐ ? 
experiences of the continuity of their care. In this 
paper we present data showing the development and 
psychometric validity of the Medical Care 
Questionnaire (MCQ).  
 
Methods 
The development of the MCQ was carried out in four 
phases. Phase 1 was a literature review to determine 
whether existing instruments could be used or 
adapted for outpatient oncology. Phase 2 included 
modification of an existing instrument (Components of 
Primary Care Index (CPCI)) [8] by expert review. Phase 
3 was a pilot study to explore the psychometric 
properties of the refined instrument in a patient 
population. The results of Phase 3 suggested further 
modification of the instrument, so Phase 4 examined 
the validity of the instrument in a larger patient 
sample. Each phase was carried out sequentially and 
data for Phases 3 and 4 were collected from the same 
medical oncology outpatient clinic. Table 1 
summarises the aims and methods for each phase of 
instrument development. 
 
Phase 1: Literature Review 
A literature search was performed in Medline, using 
the ŬĞǇ ǁŽƌĚƐ  ?ĐŽŶƚŝŶƵŝƚǇ ŽĨ ĐĂƌĞ ? ? ĐŽ-ordination of 
ĐĂƌĞ ? ?  ?ƉĂƚŝĞŶƚ ƐĂƚŝƐĨĂĐƚŝŽŶ ? E  ?ĐĂŶĐĞƌ ? ? The 
purpose of the review was twofold: 1) to identify 
ĚĞĨŝŶŝƚŝŽŶƐ ŽĨ  ?ĐŽŶƚŝŶƵŝƚǇ ĂŶĚ ĐŽ-ŽƌĚŝŶĂƚŝŽŶ ŽĨ ĐĂƌĞ ?
applicable to secondary/tertiary hospital care; and 2) 
to find instruments that measure coordination and 
ĐŽŶƚŝŶƵŝƚǇŽĨŵĞĚŝĐĂůĐĂƌĞ ĨƌŽŵƉĂƚŝĞŶƚƐ ?ƉĞƌƐƉĞĐƚŝǀĞ ? 
The literature review did not identify any self-reported 
instruments suitable for hospital based oncology 
practices. One instrument, the Components of Primary 
Care Index (CPCI), which was designed for use in 
primary health care, was found to employ a useful 
taxonomy and included a number of items and 
subscales that were of relevance to the cancer care 
setting. This questionnaire consists of 19 items, 
ŽƌŐĂŶŝǌĞĚ ŝŶƚŽ  ? ĚŽŵĂŝŶƐ  ?WĂƚŝĞŶƚ ƉƌĞĨĞƌĞŶĐĞ ƚŽ ƐĞĞ
ƵƐƵĂů ĚŽĐƚŽƌ ? ?  ?/ŶƚĞƌƉĞƌƐŽŶĂů ĐŽŵŵƵŶŝĐĂƚŝŽŶ ? ?
 ?WŚǇƐŝĐŝĂŶ ?Ɛ ĂĐĐƵŵƵůĂƚĞĚ ŬŶŽǁůĞĚŐĞ ŽĨ ƚŚĞ ƉĂƚŝĞŶƚ ? ?
ĂŶĚ  ?Ž-ŽƌĚŝŶĂƚŝŽŶ ŽĨ ĐĂƌĞ ? ?The internal consistency 
reliability of the 4 subscales ranged between 0.68 and 
0.79. The instrument demonstrates good 
psychometric properties and was originally developed 
and evaluated in a sample of 2899 primary care 
ƉĂƚŝĞŶƚƐ ǀŝƐŝƚŝŶŐ  ? ? ? ĨĂŵŝůǇ ƉŚǇƐŝĐŝĂŶƐ ? ŽĨĨŝĐĞƐ ŝŶ ƚŚĞ
USA [8, 9]. All items have a 5-point Likert scale 
response format anchored by strongly agree and 
strongly disagree. The way in which items are phrased 
requires patients to report rather than rate their 
interaction with the physician. Since cancer patients 
are typically reluctant to rate their physicians poorly 
[6], the less judgemental reporting style may serve to 
reduce ceiling effects from responses.  
 
Phase 2: Expert Review 
Whilst the CPCI provides a valuable scale structure and 
taxonomy, many items are phrased in a manner 
unsuitable for the purposes of team-based hospital 
care. The CPCI was reviewed for applicability to 
outpatient oncology by an expert panel of 3 consultant 
medical oncologists and the experimenter (GV) an 
oncologist in training. The experts were selected from 
medical oncology and were chosen as they had 
experience in managing team-based patient care 
across different cancer specialities. A stepwise 
procedure (similar to the Delphi technique) was used 
to adapt the original CPCI and consensus was reached 
for each decision to alter, remove, or add an item. The 
first step included a review of item content to 
determine applicability to cancer patients. The second 
step examined the wording of the remaining items and 
the final step was item generation to replace items 
that had been removed. See Table 2 for each 
modification step. The modified questionnaire was 
renamed the Medical Care Questionnaire (MCQ). 
 
Phase 3 and 4: Evaluating the psychometric 
properties of the new instrument 
In Phase 3, as part of an outpatient audit 285 cancer 
patients were invited to complete the new MCQ 
instrument during their visit to the hospital or by post. 
Of those contacted, 200 (70%) patients returned 
completed questionnaires. For Phase 4, MCQ 
responses were collected from patients taking part in 
two separate studies. The first study was a postal audit 
to determine patient experiences of their care; 313 
cancer patients were contacted by post and asked to 
complete and return the MCQ. Two hundred and 
fifteen (69%) completed questionnaires were 
returned. The second study was a randomised 
controlled trial (RCT) examining the impact of routine 
quality of life assessment on patient-doctor 
communication [10]. In this study patients were asked 
to complete the MCQ at baseline. Of the 286 cancer 
patients who took part in the RCT 262 (92%) 
completed the MCQ. In total, 477 patients completed 
the MCQ questionnaire in Phase 4. 
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The MCQ was administered at a regional hospital 
(North England) with a specialist cancer service 
(Medical Oncology Unit). The audits carried out in 
Phases 3 and 4 were performed as part of a service 
improvement and as such were not subject to NHS 
ethical approval. Adult patients from all tumour 
groups attending the Medical Oncology Unit were 
eligible to take part in Phases 3 and 4, provided they 
could read and understand English and in the opinion 
of the investigator they were not exhibiting overt 
cognitive dysfunction or signs of distress. The Phase 4 
RCT received NHS ethical approval and all patients 
gave written informed consent prior to data collection 
in accordance with the Declaration of Helsinki.  
 
Demographic Details 
For all studies in Phases 3 and 4 patient medical 
details, such as the primary tumour site, were 
recorded from medical notes. Patients completed a 
socio-demographic survey which included details on 
the ƉĂƚŝĞŶƚƐ ? ĂŐĞ ? ŐĞŶĚĞƌ ? ŵĂƌŝƚĂů ƐƚĂƚƵƐ ? ĂŶĚ
employment status. Medical and social demographic 
details are summarised in Table 3. Patients were 
predominantly female (81% in Phase 3; 74% in Phase 
4) and diagnoses of gynaecological, breast, and 
genitourinary cancers were most common. The biases 
in distribution of gender and diagnosis reflect the 
demographics of the unit, with three specialised clinics 
in breast and gynaecological cancers and one general 
oncology clinic.  
 
Sample Size 
For factor and multitrait analyses, sample size is 
typically recommended to require 5-10 times the 
number of participants as the number of items 
included in the instrument [11]. In Phase 3, the MCQ 
included 21 items and was completed by 200 patients, 
giving a subject to item ratio of 9.5:1. In Phase 4, the 
MCQ contained 15 items and was completed by 477 
patients, giving a subject to item ratio of 31.8:1.  
 
Descriptive analysis 
In Phase 3, descriptive data were examined to assess 
the acceptability of each item to patients and to 
evaluate the contribution of each item to the scale. 
Positively worded items on the MCQ were reversed 
scored to be consistent with the remaining items. 
After recoding, a lower score on each item indicated 
poorer perception of continuity and coordination of 
care. Criteria for retaining items included: 1) response 
ranges spanned 3 or more response categories (i.e., 
categories 1 through to 4, or 2 through to 5 were 
selected); 2) ŵĞĂŶ ǀĂůƵĞƐ A? ?; and 3) no ceiling effect 
i.e. frequency of responses for less favourable 
response categories should be > 20%. Items not 
meeting these criteria were removed prior to 
exploratory factor analysis as they were deemed likely 
to contribute to a ceiling effect. 
 
Exploratory Factor Analysis 
Kolmogorov-Smirnov tests showed the MCQ data in 
both Phases 3 and 4 were not normally distributed 
(p<.05), therefore the latent structure of the 
instrument was examined using principle axis 
factoring. Oblique (direct oblimin) rotation was 
applied because the original CPCI reported that the 
factors  ?ĐŽŽƌĚŝŶĂƚŝŽŶ ? ĂŶĚ  ?ĂĐĐƵŵƵůĂƚĞĚ ŬŶŽǁůĞĚŐĞ ?
were correlated [8] and correlations between factors 
were expected for current data. The criteria for factor 
extraction were a minimum eigenvalue of 1.00 and 
that each component accounted for at least 5% of the 
variance among items. Scree plots assisted the 
decision to retain factors. Data with more than 40% 
missing values were removed prior to analysis and 
remaining missing data were replaced by mean values 
for the item.  
 
Confirmatory Factor Analysis 
The suggested factor structure of the MCQ (from 
Phase 3 exploratory factor analysis) was examined 
using confirmatory factor analysis (CFA) with data in 
Phase 4. Goodness of fit of was deemed acceptable if 
the chi square value was low with a non-significant p-
value, and if the RMSEA was below 0.080. 
 
Reliability 
In Phase 4 the reliability of each subscale was 
examined using multitrait analysis. This analysis 
examined the item-convergent and item-discriminant 
validity of the subscales that were derived from Phase 
3 exploratory factor analysis and supported by Phase 4 
confirmatory factor analysis. Item convergent validity 
was supported if items had correlations >0.40 with 
their own hypothesised subscale. Item-discriminant 
validity was supported if items correlated more highly 
with their own hypothesised subscale than they did 
with other subscales. The internal consistency 
reliability of each subscale and the total scale was 
ĂƐƐĞƐƐĞĚ ďǇ ĐĂůĐƵůĂƚŝŶŐ ƌŽŶďĂĐŚ ?Ɛ ĂůƉŚa  ?ɲ ?
coefficients. Values above 0.70 were accepted as 
moderate, whilst values above 0.80 were accepted as 
showing good internal consistency.  
 
Validity 
In Phase 4 aŶ ŽďũĞĐƚŝǀĞ ŵĞĂƐƵƌĞ ŽĨ  ?ĐŽŶƚŝŶƵŝƚǇ ŽĨ
ĐĂƌĞ ? ǁĂƐderived to explore the external validity of 
the MCQ. The literature describes several indexes for 
continuity of care developed mainly for family practice 
[12]. The simplest measure considers the number of 
visits each patient has made and the number of care 
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providers seen ?ƚŚŝƐŝƐĐĂůůĞĚƚŚĞ ?<ŝŶĚĞǆ ?[13, 14]. The 
K index can be applied to a team-based hospital 
oncology practice by recording the number of doctors 
each patient has seen and the total number of clinic 
visits over time.  
 
K index = (Number of visits  W Number of doctors) / 
(Number of visits  W 1)  
 
The K index has a value between 0 and 1. When a 
patient has seen only one doctor over time the K index 
will be 1. When a patient has seen different doctors at 
each visit, the K index will be 0. 
 
The validity of the MCQ subscales was explored 
against medical and demographic known groups. MCQ 
subscale scores were derived by computing the mean 
of subscale items and linearly transforming the data to 
a 0-100 scale. One-way Analysis of Variance (ANOVA) 
tests (with Bonferroni corrections for post hoc 
analyses) were carried out to determine any 
differences in subscale scores for the following groups: 
diagnosis (breast, genitourinary, gynaecological, 
melanoma, sarcoma, or other); and K index quartiles 
(quartiles were calculated using SPSS to identify the 
score boundaries for the 25
th
, 50
th
, and 75
th
 
percentiles: 1
st
=0-0.24; 2
nd
=0.25-0.49; 3
rd
=0.50-0.59; 
4
th
=0.60-1.00). Independent samples t-tests compared 
subscale scores between age groups (under or over 60 
years) and between genders.  
 
Data were analysed using SPSS version 16.0 for 
Windows and LISREL 8.80 Student. The threshold for 
statistical significance was set at p<0.05. Effect sizes 
for ANOVAs (CŽŚĞŶ ?Ɛ f) were calculated using 
G*Power 3.0.10 [15]. ŽŚĞŶ ?Ɛf values are interpreted 
as small=0.10, medium=0.25, and large=0.40 [16]. 
 
Results 
Phase 2: Expert Review 
Five items were removed from the original CPCI 
instrument because they were not considered 
applicable to the cancer outpatient population. Minor 
changes were made to 8 items, such as the 
ƌĞƉůĂĐĞŵĞŶƚŽĨ  ?ƚŚŝƐĚŽĐƚŽƌ ?ǁŝƚŚ  ?ƚŚĞĚŽĐƚŽƌƐ ?Žƌ ƚŚĞ
addition of a few words to specify tŚĞƐĞƚƚŝŶŐ ?ŝ ?Ğ ? ? ?ƚŚŝƐ
ĐůŝŶŝĐ ? ? ĂŶĚ ŵĂũŽƌ ĐŚĂŶŐĞƐ ǁĞƌĞ ŵĂĚĞ ƚŽ ƚǁŽ ŝƚĞŵƐ ? 
Seven new items were added to the instrument, which 
covered aspects of medical care specific to oncology 
and the system of delivery of cancer care. The expert 
review resulted in a 21-item instrument renamed the 
Medical Care Questionnaire (MCQ). See Table 2 for 
the expert review stages including the original CPCI 
items and the adapted MCQ items. 
 
Phase 3: Descriptive Analysis 
The proportion of missing responses to the 21-item 
MCQ was low (1%-5%). Five items did not meet the 
criteria for retention because they had high mean 
scores (range 4.4 - 4.5 across items) and had a low 
cumulative frequency of less favourable responses 
(range 9%-12% across items). As such these five items 
were removed. One item  ? ?/ ĚŽŶ ?ƚ ŵŝŶĚ ƐĞĞŝŶŐ
different doctors because everyone in the team knows 
ŵǇ ĐĂƐĞ ? ?was deleted despite meeting the criteria 
because it was a double statement with ambiguous 
meaning. After descriptive analysis the MCQ 
instrument was reduced to 15-items. These remaining 
items were subject to exploratory factor analysis. 
 
Phase 3: Exploratory factor analysis and 
reliability 
Three factors were extracted with eigenvalues greater 
than 1 and which accounted for at least 5% of variance 
in the data. Examination of the inflexion point of the 
Scree plot confirmed the retention of 3 factors. The 3 
factors accounted for 45.47% of the common variance 
and were labelled:  ?ŽŽƌĚŝŶĂƚŝŽŶ ? ǁŚŝĐŚ ŝŶĐůƵĚĞĚ
items on the coordination of patient information and 
accumulated physician knowledge about the patient; 
 ?WƌĞĨĞƌĞŶĐĞƐ ? ǁŚŝĐŚ ŝŶĐůƵĚĞĚ ŝƚĞŵƐ ŽŶ ƉĂƚŝent 
preferences to see their usual doctor; and 
 ?ŽŵŵƵŶŝĐĂƚŝŽŶ ? ǁŚŝĐŚ ŝŶĐůƵĚĞĚ ŝƚĞŵƐ ŽŶ
communication with doctors and knowledge about 
non-medical issues. Each of the three subscales 
showed satisfactory internal consistency (ƌŽŶďĂĐŚ ?Ɛ
alpha) ŽŽƌĚŝŶĂƚŝŽŶɲA? ? ? ? ? ?WƌĞĨĞƌĞŶĐĞƐɲA? ? ? ? ?; and 
Communication ɲ= 0.80. The subscale scores were 
interpreted as follows: patients with higher 
 ?Communication ? and  ?Coordination ? scores on the 
MCQ rated their communication with doctors and 
coordination of their medical information as better 
than patients with lower scores; patients with higher 
 ?Preferences ? subscale scores had a stronger 
preference for seeing their usual doctor (or fewer 
doctors) during clinic visits than patients with lower 
scores. 
 
Phase 4: Confirmatory factor analysis 
The 3 factor model derived by exploratory factor 
analysis (EFA) of the Phase 3 data was examined in the 
Phase 4 data with confirmatory factor analysis (CFA). 
We were concerned that the Coordination subscale 
derived by EFA could have been an artefact because 
the items contributing to this subscale were all 
negatively worded. To determine whether the 
Coordination subscale should be kept as an 
independent subscale or merged with the 
Communication subscale, we compared the goodness 
of fit of two models. The first model contained 2 
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factors: factor 1 combined all items from the 
Coordination and Communication subscales and factor 
2 contained the items from the preferences subscale. 
The second model contained 3 factors, with the items 
remaining within the 3 factors described in the Phase 
3 EFA.  
 
The 2 factor model had poorer fit than the 3 factor 
model. Goodness of fit for 2 factor model: X
2
=405.04; 
df=89; p=.000; RMSEA=0.086; Confidence Interval of 
RMSEA = 0.078-0.095. The modification indices 
suggested adding paths between factor 1 (combined 
Coordination / Communication subscale) and item 13; 
and paths between the Preferences subscale and 
items 1, 2, 8, and 14. The 3 factor model showed 
improvement in goodness of fit compared to the 2 
factor model: X
2
=269.15; df=87; p=.000; RMSEA = 
0.066; Confidence Interval of RMSEA = 0.057-0.075. 
The modification indices suggest adding a path 
between the Preferences subscale and item 1 and 
adding paths between the Communication subscale 
and items 1 and 13.  
 
Despite the improvement in fit between the 2 factor 
and the 3 factor models, the chi square value 
remained high and significant. However, the chi 
square is often reported to be inflated by large sample 
sizes, and the acceptable RMSEA score for the 3 factor 
model suggested adequate fit of the 3 factor model. 
The reliability of the 3 factor model was explored 
further with multitrait analyses, to determine whether 
any items should be removed or moved from the 
three subscales.   
 
Phase 4: Multitrait Item-Subscale Correlations 
Data from Phase 4 was used to examine item-
convergent and item-discriminant validity of the 3 
factor domain structure using multitrait correlation 
analyses (Table 4). Items 1 and 10 showed low item-
convergent validity (0.36 for both items) with the 
Coordination subscale but did not show higher 
correlations with other subscales. Item 11 showed low 
item-convergent validity (0.38) with the 
Communication subscale, but did not have a higher 
correlation with any other subscale. Item 13 showed 
good item-convergent validity with the Preferences 
subscale. The Coordination and Communication 
subscales were positively correlated (r(469)=0.45, 
p<.001). The internal consistency  ?ƌŽŶďĂĐŚ ?Ɛ ĂůƉŚĂ ?
for the three subscales was: Communication=0.69; 
Preferences=0.84; and Coordination=0.75. CƌŽŶďĂĐŚ ?Ɛ
alpha  ?if item deleted ? values were examined to 
determine whether the subscales would be improved 
with the removal of items 1, 10 and 11. ƌŽŶďĂĐŚ ?Ɛ
alpha for the Coordination subscale showed no 
improvement for removing item 10 and showed only a 
small improvement of 0.01 with the removal of item 1. 
ƌŽŶďĂĐŚ ?Ɛ ĂůƉŚĂfor the Communication subscale 
showed no improvement with the removal of item 11. 
We decided to retain items 1, 10, and 11, and 13 in the 
original subscales, as suggested by Phase 3 EFA.  
 
Phase 4: Known Groups Comparisons 
Patients were divided into groups based on 
demographic and medical details and their scores on 
the MCQ subscales were compared (Table 5). Patients 
with breast cancer had lower Coordination subscale 
scores (F(5, 468)=2.53, p=0.028, f=0.16) than patients 
with melanoma cancer but had higher Preferences 
subscale scores (F(5, 451)=3.75, p=0.002, f=0.20) than 
patients with gynaecological cancer. Breast cancer 
patients also had lower Communication subscale 
scores (F(5, 465)=3.09, p=0.009, f=0.18) than patients 
with gynaecological (p=0.027) or melanoma (p=0.050) 
cancers. Individuals with the highest K index (4th 
quartile) had higher Preferences subscale scores (F(3, 
435)=6.46, p=0.000, f=0.21) than patients from lower 
K index quartile groups (1
st
 quartile p=0.083; 2
nd
 
quartile p<0.001; 3
rd
 quartile p=0.049). There were no 
between group differences by K index quartile for 
Coordination or Communication subscale scores. 
There were no between group differences in MCQ 
subscale scores for age group or gender.  
 
Discussion 
We have presented the various stages of development 
and validation of the MCQ, to measure oncology 
ƉĂƚŝĞŶƚƐ ? ƉĞƌĐĞƉƚŝŽŶƐ ŽĨ ƚŚĞ ĐŽŶƚŝŶƵŝƚǇ ĂŶĚ
coordination of their medical care and communication 
with their doctors. The MCQ was adapted from the 
Components of Primary Care Index by a process of 
expert review and psychometric evaluation. This 
process led to a number of changes being made to the 
original 19-item CPCI to make it applicable to an 
oncology setting. This included removing or rewording 
items and generating new items. Although the item 
adaptation process was based on consensus methods 
using expert reviewers, it could have been improved 
by including patient opinions and feedback. Although 
not reported in this study, patient feedback was 
elicited during Phase 3. During this phase patients 
were encouraged to comment on the items and give 
feedback on the questionnaire. Patient feedback was 
analysed qualitatively and was taken into 
consideration alongside the descriptive analysis. In 
summary most patients confirmed the importance of 
the identified subscales: many patients reported that 
it was important for them to see the same doctor at 
each visit and that the coordination of their medical 
information between individual doctors and the wider 
medical team was very important to their care. The 
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adapted instrument was renamed the MCQ and 
contained 21 items.  
 
Initial psychometric evaluation of the 21-item MCQ 
suggested removal of 5 items that contributed to a 
ceiling effect in responses. Of these items, two were 
from the original CPCI questionnaire, two were 
adapted from the original CPCI, and one was a new 
item. One additional new item was removed as it was 
considered a double statement and was ambiguous to 
interpret. The psychometric evaluation of the 
remaining 15 items suggested the MCQ measured 
three ĚŽŵĂŝŶƐŽĨĐŽŶƚŝŶƵŝƚǇŽĨĐĂƌĞ P ?ommunication ? 
with doctors;  ?oordination ? of medical information 
ĂŶĚ ƉŚǇƐŝĐŝĂŶƐ ? ĂĐĐƵŵƵůĂƚĞĚ ŬŶŽǁůĞĚŐĞ ĂďŽƵƚ ƚŚĞ
patient; ĂŶĚ  ?WreferenceƐ ? to see usual doctor. The 
 ?WƌĞĨĞƌĞŶĐĞƐ ? ƐƵďƐĐĂůĞ ƌĞŵĂŝŶĞĚ ĨƌŽŵ ƚŚĞ ŽƌŝŐinal 
W/ ?ǁŝƚŚƚŚĞĂĚĚŝƚŝŽŶŽĨĂŶĞǁŝƚĞŵ ?ŝƚĞŵ ? ? ?/ƌĂƌĞůǇ
ƐĞĞ ƚŚĞ ƐĂŵĞ ĚŽĐƚŽƌ ǁŚĞŶ / ĐŽŵĞ ƚŽ ƚŚŝƐ ĐůŝŶŝĐ ? ?
Subsequent evaluation of the hypothesised domains in 
a new patient population showed that the three 
subscales had reasonable internal and external 
reliability and validity in the target population. Whilst 
the item-factor structure of the MCQ differs from the 
CPCI, the two instruments remain conceptually similar 
ŝŶ ƚŚĞ ŵĞĂƐƵƌĞŵĞŶƚ ŽĨ ƉĂƚŝĞŶƚƐ ? ƉƌĞĨĞƌĞŶĐĞƐ ƚŽ ƐĞĞ
their usual doctor, their evaluation of communication, 
and their perception of the coordination of their 
medical information between doctors. The differences 
in factor structure between the two instruments might 
be expected given the removal of seven original CPCI 
items and the addition of three new items to the 
MCQ. The differences in factor structure may also be 
due to differences in medical setting (primary versus 
secondary/tertiary care) and the different patient 
population sampled in the current study.  
 
After item deletion in Phase 3, the 15-item MCQ was 
administered to a new oncology outpatient population 
in Phase 4. This data was used to re-examine the 
hypothesised domain structure and internal validity of 
the MCQ and examined its external validity by 
comparing known groups. Although this second 
administration of the 15-item MCQ showed slightly 
poorer internal validity of the subscales than in the 
previous sample, each subscale showed reasonable 
internal consistency and reliability and appears 
suitable for use in a mixed oncology outpatient 
population.  
 
The Communication domain of the MCQ is an element 
of continuity of care that was not identified by 
Freeman et al [5] as being important to continuity of 
care. However, in oncology, it is important that the 
patients and doctors maintain good levels of 
communication to enable the identification of 
symptoms and toxicities during treatment and to 
monitor the impact of disease and treatment on 
broader social and psychological well being. The items 
in the communication domain of the MCQ reflect the 
importance of communication about non-medical 
ŝƐƐƵĞƐ ǁŝƚŚ ŝƚĞŵƐ ƐƵĐŚ ĂƐ P  ?dŚĞ ĚŽĐƚŽƌƐ ŬŶŽǁ ŚŽǁ /
ĨĞĞů ĞŵŽƚŝŽŶĂůůǇ ǁŚŝůĞ ƚŚĞǇ ĂƌĞ ƚƌĞĂƚŝŶŐ ŵĞ ? ?  ?dŚĞ
doctors know about non-ŵĞĚŝĐĂůƚŚŝŶŐƐŝŶŵǇůŝĨĞ ?ĂŶĚ
 ?/ ĐĂŶ ĞĂƐŝůǇ ƚĂůŬ about person things with the 
ĚŽĐƚŽƌƐ ? ?Amongst the patient groups we found that 
patients with breast cancer reported lower 
Communication scores than patients with 
gynaecological and melanoma cancers. 
 
The Coordination domain of the MCQ was considered 
to rĞĨůĞĐƚ ƉĂƚŝĞŶƚƐ ? ĞǆƉĞƌŝĞŶĐĞs of continuity when 
they saw different doctors for their medical care. 
Although we have given this subscale the label 
Coordination, it is clear from the items included in this 
domain that ƉĂƚŝĞŶƚƐ ?ĞǆƉĞƌŝĞŶĐĞs of coordination are 
dependent on the quality of communication and the 
flow of information between health professionals and 
across clinic visits. As may be expected, we found the 
Communication and Coordination subscales were 
correlated. In line with this correlation we found that 
patients with breast cancer reported lower 
Communication scores than patients with 
gynaecological and melanoma patients also reported 
lower Coordination subscale scores than patients with 
melanoma cancer.  
 
The Preferences subscale was considered to reflect 
the importance that patients place in seeing the same 
health professional at each hospital visit. This has been 
identified in previous research as an important 
component of continuity of care [4, 5]. We found a 
small negative correlation between the Preferences 
subscale and the Coordination subscale suggesting 
that those patients who rated the coordination of 
their medical information between doctors as poor 
might be more likely to place greater value in seeing 
fewer health professionals for their medical care. In 
this study patients with breast cancer were more likely 
than patients with gynaecological cancer to endorse 
items from the Preferences subscale. Perhaps counter 
intuitively we found that patients with high K index 
values (who saw a fewer doctors per hospital visit) 
were more likely to endorse items from the 
Preferences subscale. This result may reflect that 
some clinics within the Medical Oncology Unit 
endeavour to accommodate patients who have strong 
preferences to see a particular doctor for their clinic 
visit. It could be that a number of patients with higher 
scores on the Preferences subscale were more active 
in ensuring their care was delivered by particular 
health professionals.  
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There were several limitations to this study. Although 
we believe our sample provided good representation 
of the patient population seen in the Medical 
Oncology Unit, the majority of the patients were 
female with breast or gynaecological cancers and the 
results may be biased towards female opinion. Whilst 
the comparison of MCQ subscales scores between 
males and females did not show any significant 
differences, further validation of the questionnaire to 
include a larger number of men with cancer would be 
desirable. Another limitation to generalised 
interpretation of the results is that the study phases 3 
and 4 were carried out in a single Medical Oncology 
Unit, part of a tertiary referral cancer centre. A typical 
feature of this setting is the large number of doctors 
looking after the patients (teams of approximately 4-8 
doctors), which was reflected in the relatively low K-
index in our study populations. Thus, further 
validation of the MCQ may be required before it is 
applicable to hospitals where the oncology care is 
delivered by a smaller team of doctors.  
 
Whilst the validity of the MCQ has been shown to be 
good in a general cancer population, it is important 
that further work is carried out to establish test-retest 
validity and to gather stronger data on the relationship 
between patient scores and indicators of clinical 
practice that are predicted to affect continuity of 
medical care. Until the psychometric properties of the 
MCQ have been validated further we recommend that 
patient responses to the MCQ are interpreted at the 
level of the three domains rather than calculating a 
15-tem total score.  
 
We have provided preliminary evidence that the MCQ 
instrument can provide valuable information on 
ƉĂƚŝĞŶƚƐ ? ĞǆƉĞƌŝĞŶĐĞƐ ŽĨ ĐŽŵŵƵŶŝĐĂƚŝŶŐ ǁŝƚŚ ĚŽĐƚŽƌƐ
and their perceptions of the continuity and 
coordination of their medical care. The MCQ 
instrument is brief (5-10 minutes to complete), easy to 
administer, and is simple to score, therefore we feel it 
would be a valuable and suitable patient-reported 
measure to be used in busy oncology practice, clinical 
trials and service improvement programmes. 
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Table 1 Aims and methods for each study phase 
 
Phase Year Aim Procedure 
Phase 1 1999 Review literature relevant to 
continuity of care issues for 
outpatient oncology and identify 
relevant instruments 
1. Literature search 
2. Review existing instruments 
Phase 2 1999 Obtain expert opinion on the 
relevance of the CPCI and to modify 
the instrument to be applicable to 
outpatient oncology practice 
1. Expert review of CPCI 
2. Removal of incompatible items 
3. Rewording existing items 
4. Construction of new items 
Phase 3 1999-
2000 
Test the acceptability and relevance 
of the adapted questionnaire and 
explore its measurement properties 
1. Patient completion of questionnaire 
2. Descriptive analysis and modification 
of questionnaire 
3. Psychometric exploration of factor 
structure  
Phase 4 2000-
2003 
Examine the hypothesised subscales 
in a new patient population. Explore 
the validity of the modified 
questionnaire between groups. 
1. Patient completion of questionnaire 
2. Patient completion of secondary 
instruments 
3. Psychometric exploration of factor 
structure, reliability, validity, and 
known groups  
 
CPCI, Components of Primary Care Index 
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Table 2 Adaptation process of CPCI to MCQ showing item wording and factor loading of final MCQ items 
 Phase 2 Expert Review Phase 3 Psychometric 
Evaluation 
Original 19-item CPCI 21-item MCQ *Facto
r 
Factor 
Loading 
Final 
MCQ 
Item 
Number 
I rarely see the same doctor  when 
I go for medical care 
I rarely see the same doctor  
when I come to this clinic 
1 .403 1 
Sometimes this doctor does not 
listen to me 
Sometimes the doctors do not 
listen to me 
1 .506 2 
I want one doctor to co-ordinate all 
the health care I receive 
I want one doctor to co-ordinate 
all the care I receive 
2 .639 3r 
This doctor communicates with the 
other health care providers I see 
The doctors I see in this clinic 
communicate with each other 
3 .555 4r 
This doctor do not always know my 
medical history very well 
The doctors do not always know 
my medical history and  problems 
very well 
1 .678 5 
My medical care improves when I 
see the same doctor that I have 
seen before 
My medical care improves when I 
see the same doctor that I have 
seen before 
2 .620 6r 
It is very important to me to see 
my regular doctor 
It is very important to me to see 
my regular doctor 
2 .878 7r 
This doctor and I have been 
through a lot together 
The doctors know how I feel 
emotionally while they are 
treating me 
3 .785 8r 
This doctor does not always know 
about care I have received at other 
places 
The doctors do not always know 
about the care and treatment I 
have received  previously in this 
clinic 
1 .677 9 
/ĚŽŶ ?ƚĂůǁĂǇƐĨĞĞůĐŽŵĨŽƌƚĂďůĞ 
asking questions of this doctor 
/ ĚŽŶ ?ƚ ĂůǁĂǇƐ ĨĞĞů ĐŽŵĨŽƌƚĂďůĞ
asking the doctors questions 
1 .513 10 
This doctor knows a lot about the 
rest of my family 
The doctors know about non-
medical things in my life (family, 
job, hobbies, social life) 
3 .642 11r 
NEW I sometimes have to repeat my 
problems to the different doctors 
I see in this clinic 
1 .506 12 
NEW I would rather wait for the doctor 
who saw me last  than be seen by 
the next available doctor in clinic 
2 .736 13r 
NEW The doctors usually know about 
the problems that have bothered 
me at the previous visits 
3 .591 14r 
I can easily talk about personal 
things with this doctor 
I can easily talk about personal 
things with the doctors 
3 .458 15r 
How many years have you been a 
patient of this physician? 
REMOVED  
I go to this doctor for almost all of 
my medical care 
REMOVED  
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If I am sick, I would always contact 
a doctor in this office first 
REMOVED  
This doctor clearly understand my 
health needs 
The doctors clearly understand 
my medical needs 
REMOVED 
This doctor knows the results of my 
visits to other doctors 
The doctors know the results of 
my previous visits to this clinic 
REMOVED 
This doctor always follow up on a 
ƉƌŽďůĞŵ/ ?ǀĞŚĂĚ ?ĞŝƚŚĞƌĂƚƚŚĞŶĞǆƚ
visit or by phone 
The doctors always follow up on a 
ƉƌŽďůĞŵ/ ?ǀĞŚĂĚďĞĨŽƌĞ 
REMOVED 
This doctor always explain things to 
my satisfaction 
The doctors always explain things 
to my satisfaction 
REMOVED 
NEW The doctors I see in this clinic 
know what my treatment or care 
plan is 
REMOVED 
NEW / ĚŽŶ ?ƚ ŵŝŶĚ ƐĞĞŝŶŐ ĚŝĨĨĞƌĞŶƚ
doctors because everyone in the  
team knows my case 
REMOVED 
 
* The three factors were labelled as follows: factor 1 =  ?Coordination ? of medical ŝŶĨŽƌŵĂƚŝŽŶ ĂŶĚ ƌ ?Ɛ
accumulated knowledge about patient; factor 2 =  ?Wreferences ? to see usual doctor; and 3 = 
 ?ommunication ? with doctor. 
r represents that the item has been reversed scored 
CPCI, Components of Primary Care Index; MCQ, Medical Care Questionnaire 
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Table 3 Patient demographic and clinical details for study phases 3 and 4  
 
 
 
 
 
K index = (Number of visits  W Number of doctors) / (Number of visits  W 1)  
K index has a value between 0 and 1, when a patient has seen only one doctor over time K index = 1. When 
a patient has seen different doctors at each visit, the K index = 0. 
 Phase 3 
N=200 
Phase 4 
N=477 
Sex, n (%)   
   Female 162 (81%) 354 
(74.2%) 
   Male 38 (19%) 123 
(25.8%) 
Age Group (years), n (%)   
   15-29 8 (4%) 14 (2.9%) 
   30-44 27(13.5%) 74 (15.5%) 
   45-59 84 (42%) 195 
(40.9%) 
   60-74 67 (33.5%) 160 
(33.5%) 
   75+ 14 (7%) 34 (7.1%) 
K index, median (range) 0.3 (0-1) 0.50 (0-1) 
Marital status, n (%)   
   Single 12 (6%) 30(6.3%) 
   Married/ cohabiting 148 (74%) 358 
(75.1%) 
   Divorced/widowed 37 (18.5%) 84 (17.6%) 
   Missing 3 (1.5%) 5 (1.0%) 
Employment status, n (%)   
   Working full time 26 (13%) 211 
(44.2%) 
   Working part time 23 (11.5%) 43 (9.0%) 
   On sick leave 51 (25.5%) 58 (12.2%) 
   Homemaker 16 (8%) 40 (8.4%) 
   Retired 76 (38%) 112 
(23.5%) 
   Other 4 (2%) 5 (1.0%) 
   Missing 4 (2%) 8 (1.7%) 
Diagnosis, n (%)   
   Breast cancer 53 (26.5%) 112 
(23.5%) 
   Gastrointestinal 9 (4.5%) 0  
   Genitourinary 33 (16.5%) 102 
(21.4%) 
   Gynaecological  76 (38%) 161 
(33.8%) 
   Melanoma 2 (1%) 40 (8.4%) 
   Sarcoma 11 (5.5%) 36 (7.5%) 
   Other 16 (8%) 26 (5.5%) 
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Table 4 Multitrait item-subscale correlations (phase 4) 
 
 
* Item correlation with own scale, corrected for overlap 
 ?ŽƌƌĞůĂƚŝŽŶďĞƚǁĞĞŶƐƵďƐĐĂůĞƐ(subscale values derived by computing the mean of subscale items and 
linearly transforming the data to a 0-100 scale) 
MCQ, Medical Care Questionnaire 
Items in italics (1, 10, 11) indicate low item-convergent validity with own subscale 
 
 MCQ Domains 
 Coordination Preferences Communication 
Coordination - -0.292 ? 0.450 ? 
1 0.362* 0.130 0.298 
2 0.533* -0.242 0.302 
5 0.562* -0.183 0.376 
9 0.591* -0.231 0.353 
10 0.361* -0.166 0.225 
12 0.556* -0.225 0.356 
    
Preferences -0.292 ? - -0.066 ? 
3 -0.202 0.683* -0.034 
6 -0.218 0.643* -0.009 
7 -0.246 0.769* 0.009 
13 -0.276 0.645* -0.139 
    
Communication 0.450 ? -0.066 ? - 
4 0.277 -0.118 0.418* 
8 0.266 0.028 0.503* 
11 0.235 -0.052 0.379* 
14 0.344 0.019 0.504* 
15 0.409 -0.102 0.472* 
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Table 5 Known group comparisons (phase 4) 
Groups Communication Coordination Preferences 
 N Mean SD p value N Mean SD p value N Mean SD p value 
Gender    * 0.728    * 0.985    * 0.925 
Male 121 70.80 16.86  121 69.22 22.23  117 67.20 25.78  
Female 350 67.79 17.72  353 66.33 22.51  340 70.10 26.07  
             
Age    * 0.907    * 0.205    * 0.396 
< 60 280 67.74 17.61  281 66.35 21.73  272 71.10 25.78  
> 60 191 69.78 17.42  193 68.11 23.48  185 66.80 26.17  
             
Tumour Group     ?0.009     ?0.028     ?0.002 
Breast 110 63.17 18.66  111 63.03 23.30  106 77.44 21.56  
Genitourinary 102 69.32 17.34  102 66.47 23.02  99 68.50 26.58  
Gynaecological 159 69.93 16.41  161 68.83 21.14  154 64.46 28.13  
Melanoma 40 72.63 18.22  40 73.38 20.66  39 65.55 23.47  
Sarcoma 34 69.60 17.87  34 65.77 22.71  34 68.57 26.49  
Other  26 72.45 14.91  26 63.08 23.41  25 75.75 22.99  
             
K index  
Quartiles     ?0.079     ?0.177     ?0.000 
0 - 0.24 103 64.94 17.04  104 64.77 22.59  102 67.97 25.34  
0.25 - 0.49 117 69.46 18.36  117 65.25 22.90  112 62.78 28.40  
0.50 - 0.59 72 67.88 17.70  72 70.30 21.36  69 66.21 26.80  
0.60 - 1.00 161 70.53 17.19  162 69.34 22.20  156 76.02 22.79  
* P value from independent samples t-test.  
 ?WǀĂůƵĞĨƌŽŵKŶĞtĂǇEKsƐŚŽǁŝŶŐ overall group effect.  
SD, Standard Deviation 
 
 
 
 
